Physician profile
Elisha Boyd
NPI 1649895038
$2,172.47
in general payments reported to CMS, 2019-2025
19 companies · $838 in 2025
The $838 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,335 · 2025: $838.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,136 · Education: $36.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,136.47 |
| Education | $36.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $644.46 | 2024-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $235.18 | 2024-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $202.12 | 2024-2025 | |
| Amgen INC. | $145.39 | 2024-2025 | Repatha |
| Novo Nordisk INC | $140.58 | 2025 | Ozempic, Rybelsus |
| Abiomed | $112.50 | 2025 | |
| Esperion Therapeutics, INC. | $104.24 | 2024 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.86 | 2024 | Jardiance |
| Kiniksa Pharmaceuticals International, Plc | $89.11 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $81.84 | 2024 | Zio Monitor, Zio Xt Patch |
| Scpharmaceuticals INC. | $73.07 | 2024-2025 | |
| Medtronic, INC. | $53.51 | 2024 | Linq II |
| Alnylam Pharmaceuticals INC. | $46.62 | 2025 | Amvuttra |
| Janssen Pharmaceuticals, INC | $37.51 | 2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $34.34 | 2024-2025 | Wainua, Farxiga |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $27.84 | 2024 | Selectra |
| Lexicon Pharmaceuticals, INC. | $19.20 | 2024 | |
| Pfizer INC. | $15.95 | 2025 | |
| Boston Scientific Corporation | $15.15 | 2024 | Bodyguardian |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elisha Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.